The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Franchis, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.004 · Cited by 2,281
Arvaniti, V., D'Amico, G., Fede, G., Manousou, P., Tsochatzis, E., Pleguezuelo, M., & Burroughs, A. K. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.019 · Cited by 1,167
The Hyperdynamic Circulation of Chronic Liver Diseases: From the Patient to the Molecule
Iwakiri, Y., & Groszmann, R. J. (2006) · Hepatology · doi:10.1002/hep.20993 · Cited by 610
Sersté, T., Melot, C., Francoz, C., Durand, F., Rautou, P.-E., Valla, D., Moreau, R., & Lebrec, D. (2010) · Hepatology · doi:10.1002/hep.23775 · Cited by 530
Abraldes, J. G., Tarantino, I., Turnes, J., Garcia-Pagan, J. C., Rodés, J., & Bosch, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50133 · Cited by 529
The hepatic venous pressure gradient: Anything worth doing should be done right
Groszmann, R. J., & Wongcharatrawee, S. (2004) · Hepatology · doi:10.1002/hep.20062 · Cited by 524
Lebrec, D., Poynard, T., Hillon, P., & Benhamou, J.-P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112033052302 · Cited by 517
Albillos, A., de la Hera, A., González, M., Moya, J.-L., Calleja, J.-L., Monserrat, J., Ruiz-del-Arbol, L., & Alvarez-Mon, M. (2003) · Hepatology · doi:10.1053/jhep.2003.50038 · Cited by 446
Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study
Borzio, M., Salerno, F., Piantoni, L., Cazzaniga, M., Angeli, P., Bissoli, F., Boccia, S., Colloredo-Mels, G., Corigliano, P., Fornaciari, G., et al. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80134-1 · Cited by 438
Goulis, J., Armonis, A., Patch, D., Sabin, C., Greenslade, L., & Burroughs, A. K. (1998) · Hepatology · doi:10.1002/hep.510270504 · Cited by 435
Lin, R.-S., Lee, F.-Y., Lee, S.-D., Tsai, Y.-T., Lin, H. C., Rei-Hwa, L., Wan-Ching, H., Cheng-Chun, H., Sun-Sang, W., & Kwang-Juei, L. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80424-2 · Cited by 355
Infection, coagulation, and variceal bleeding in cirrhosis
Thalheimer, U., Triantos, C. K., Samonakis, D. N., Patch, D., & Burroughs, A. K. (2005) · Gut · doi:10.1136/gut.2004.048181 · Cited by 316
Arroyo, V., & Colmenero, J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00007-2 · Cited by 279
Pérez-Paramo, M., Muñoz, J., Albillos, A., Freile, I., Portero, F., Santos, M., & Ortiz-Berrocal, J. (2000) · Hepatology · doi:10.1002/hep.510310109 · Cited by 271
β‐Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta‐analysis
Senzolo, M., Cholongitas, E., Burra, P., Leandro, G., Thalheimer, U., Patch, D., & Burroughs, A. K. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02038.x · Cited by 241
Turnes, J., Garcia-Pagan, J. C., Abraldes, J. G., Hernandez-Guerra, M., Dell'Era, A., & Bosch, J. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00453.x · Cited by 226
Krag, A., Wiest, R., Albillos, A., & Gluud, L. L. (2012) · Gut · doi:10.1136/gutjnl-2011-301348 · Cited by 213
Gut microflora in the pathogenesis of the complications of cirrhosis
Garcia-Tsao, G., & Wiest, R. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2003.10.005 · Cited by 190
Frequency and Significance of Anti-gliadin and Anti-endomysial Antibodies in Autoimmune Hepatitis
Volta, U., De Franceschi, L., Molinaro, N., Cassani, F., Muratori, L., Lenzi, M., Bianchi, F. B., & Czaja, A. J. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026650118759 · Cited by 183
Bacterial Translocation in Acute and Chronic Portal Hypertension
Quigley, E. M. M., & Garcia-Tsao, G. (1994) · Hepatology · doi:10.1002/hep.1840200145 · Cited by 165
Appenrodt, B., Grünhage, F., Gentemann, M., Thyssen, L., Sauerbruch, T., & Lammert, F. (2009) · Hepatology · doi:10.1002/hep.23440 · Cited by 150
Self-citationBacterial translocation in acute and chronic portal hypertension
García–Tsao, G., Albillos, A., Barden, G. E., & West, B. A. (1993) · Hepatology · doi:10.1002/hep.1840170622 · Cited by 141
Intestinal permeability is increased in patients with advanced cirrhosis.
Pascual, S., Such, J. M., Esteban, A., Zapater, P., Casellas, J. A., Aparicio, J. R., Girona, E., Gutiérrez, A., Carnices, F., Palazón, J. M., et al. (2003) · PubMed · Cited by 137
Lab, V. H. H., Reiberger, T., Ferlitsch, A., Payer, B. A., Pinter, M., Homoncik, M., & Peck‐Radosavljevic, M. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0517-4 · Cited by 127
Self-citationNischalke, H. D., Berger, C., Aldenhoff, K., Thyssen, L., Gentemann, M., Grünhage, F., Lammert, F., Nattermann, J., Sauerbruch, T., Spengler, U., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.022 · Cited by 107
Self-citationHow to Prevent Varices From Bleeding: Shades of Grey—The Case for Nonselective β Blockers
Thalheimer, U., Bosch, J., & Burroughs, A. K. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.028 · Cited by 80
Zuckerman, M. J., Menzies, I. S., Ho, H., Gregory, G. G., Casner, N. A., Crane, R., & Hernandez, J. A. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000026307.56909.21 · Cited by 79
Beta-1 blocker improves survival of septic rats through preservation of gut barrier function
Mori, K., Morisaki, H., Yajima, S., Suzuki, T., Ishikawa, A., Nakamura, N., Innami, Y., & Takeda, J. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2326-x · Cited by 72
Worlicek, M., Knebel, K., Linde, H. ‐., Moleda, L., Schölmerich, J., Straub, R. H., & Wiest, R. (2010) · Gut · doi:10.1136/gut.2009.185413 · Cited by 66
Lymphocytic gastritis and gastric permeability in patients with celiac disease
Vogelsang, H., Oberhuber, G., & Wyatt, J. I. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8698227 · Cited by 65
Self-citationPresence of Anti-Microbial Antibodies in Liver Cirrhosis – A Tell-Tale Sign of Compromised Immunity?
Papp, M., Norman, G. L., Vitális, Z., Tornai, I., Altorjay, I., Földi, I., Udvardy, M., Shums, Z., Dinya, T., Orosz, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012957 · Cited by 60
Reiberger, T., Rutter, K., Ferlitsch, A., Payer, B. A., Hofer, H., Beinhardt, S., Kundi, M., Ferenci, P., Gangl, A., Trauner, M., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.002 · Cited by 57
Self-citationBacterial translocation: cause or consequence of decompensation in cirrhosis?
García–Tsao, G. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00006-4 · Cited by 56
Intestinal permeability in cirrhotic patients with and without ascites
Kalaitzakis, E., Johansson, J., Bjarnason, I., & Bjornsson, E. S. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520510024278 · Cited by 53
Increased intestinal permeability in malnourished patients with liver cirrhosis
Norman, K., Pirlich, M., Schulzke, J.-D., Smoliner, C., Lochs, H. H., Valentini, L., & Bühner, S. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.104 · Cited by 49
Kim, B. I., Kim, H. J., Park, J. H., Park, D. I., Cho, Y. K., Sohn, C. I., Jeon, W. K., Kim, H. S., & Kim, D. J. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06490.x · Cited by 37
Senzolo, M., Fries, W., Buda, A., Pizzuti, D., Nadal, E., Sturniolo, G. C., Burroughs, A. K., & DʼIncà, R. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.457 · Cited by 36 · cited 1×
“There is evidence that NSBB may have additional protective effects that are not related to their hemodynamic effects [35].”
Austrian Consensus on the Definition and Treatment of Portal Hypertension and its Complications
Peck‐Radosavljevic, M., Trauner, M. A., & Schreiber, F. (2005) · Endoscopy · doi:10.1055/s-2005-861464 · Cited by 29
Self-citationGastric permeability to sucrose is increased in portal hypertensive gastropathy
Giofré, M. R., Meduri, G., Pallio, S., Calandra, S., Magnano, A., Niceforo, D., Cinquegrani, M., Leo, V. D., Mazzon, E., Sturniolo, G. C., et al. (2000) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200012050-00009 · Cited by 29
Papp, M., Földi, I., Vitális, Z., Altorjay, I., Tornai, I., Udvardy, M., Fechner, K., Lakatos, P. L., Kappelmayer, J., & Antal‐Szalmás, P. (2012) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0032-1312415 · Cited by 9
Cited by
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
Angeli, P., Bernardi, M., Villanueva, C., Francoz, C., Mookerjee, R. P., Trebicka, J., Krag, A., Laleman, W., & Gines, P. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.024 · Cited by 2,905
Tsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60121-5 · Cited by 1,740
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
Albillos, A., Lario, M., & Álvarez-Mon, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.010 · Cited by 1,242
“Specifically, NOD2 and TLR2 variants impair innate host defence mechanisms, leading to increased SBP susceptibility and mortality in cirrhosis [107–111].”
BackgroundBacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
Jalan, R., Fernandez, J., Wiest, R., Schnabl, B., Moreau, R., Angeli, P., Stadlbauer, V., Gustot, T., Bernardi, M., Canton, R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.024 · Cited by 906
Self-citation
Metadata
- Authors
- Reiberger, T., Ferlitsch, A., Payer, B. A., Mandorfer, M., Heinisch, B. B., Hayden, H., Lammert, F., Trauner, M., Peck-Radosavljevic, M., & Vogelsang, H.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 58
- Issue
- 5
- Pages
- 911-921
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W1965709993
- Cited by
- 329
- References
- 40
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.